Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Etsuro Matsubara

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Rinsho Shinkeigaku = Clinical Neurology|February 10, 2009
[Neurotoxic Abeta oligomers: molecular basis for Alzheimer's disease]Etsuro Matsubara
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 15, 2012
[Melatonin agonist: a possible disease-modifying agent for Alzheimer's disease]Etsuro Matsubara
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 7, 2004
[The recent advance of treatment of Parkinson's disease]Etsuro Matsubara
Brain and Nerve = Shinkei Kenkyu No Shinpo|August 3, 2010
[Biological marker for Alzheimer's disease]Etsuro Matsubara
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 14, 2012
[Neurological findings leading up to the diagnosis]Etsuro Matsubara
No to Shinkei = Brain and Nerve|November 10, 2005
[What causes Abeta amyloidosis in the brain?]Etsuro Matsubara, Katsuhiko Yanagisawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 26, 2002
[The treatment of Parkinson's disease--adenosine A2A receptor antagonists]Etsuro Matsubara, Mikio Shoji, Koji Abe
Journal of Alzheimer'S Disease : JAD|October 4, 2021
Novel Serum Biomarkers of Neurovascular Unit Associated with Cortical Amyloid DepositionYasuhiro Aso, Noriyuki Kimura, Etsuro Matsubara
Multiple Sclerosis and Related Disorders|June 1, 2020
A case of myelin oligodendrocyte glycoprotein-antibody-associated disease presenting with tumefactive demyelinating lesionTakuya Ataka, Noriyuki Kimura, Etsuro Matsubara
Internal Medicine (Tokyo, Japan)|June 14, 2021
Myelin Oligodendrocyte Glycoprotein-antibody-associated Disorder Presenting with Corticomeningeal Encephalitis Prior to the Onset of Optic NeuritisTakuya Ataka, Noriyuki Kimura, Etsuro Matsubara
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Rinsho Shinkeigaku = Clinical Neurology|February 10, 2009
[Neurotoxic Abeta oligomers: molecular basis for Alzheimer's disease]Etsuro Matsubara
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 15, 2012
[Melatonin agonist: a possible disease-modifying agent for Alzheimer's disease]Etsuro Matsubara
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 7, 2004
[The recent advance of treatment of Parkinson's disease]Etsuro Matsubara
Brain and Nerve = Shinkei Kenkyu No Shinpo|August 3, 2010
[Biological marker for Alzheimer's disease]Etsuro Matsubara
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 14, 2012
[Neurological findings leading up to the diagnosis]Etsuro Matsubara
No to Shinkei = Brain and Nerve|November 10, 2005
[What causes Abeta amyloidosis in the brain?]Etsuro Matsubara, Katsuhiko Yanagisawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 26, 2002
[The treatment of Parkinson's disease--adenosine A2A receptor antagonists]Etsuro Matsubara, Mikio Shoji, Koji Abe
Journal of Alzheimer'S Disease : JAD|October 4, 2021
Novel Serum Biomarkers of Neurovascular Unit Associated with Cortical Amyloid DepositionYasuhiro Aso, Noriyuki Kimura, Etsuro Matsubara
Multiple Sclerosis and Related Disorders|June 1, 2020
A case of myelin oligodendrocyte glycoprotein-antibody-associated disease presenting with tumefactive demyelinating lesionTakuya Ataka, Noriyuki Kimura, Etsuro Matsubara
Internal Medicine (Tokyo, Japan)|June 14, 2021
Myelin Oligodendrocyte Glycoprotein-antibody-associated Disorder Presenting with Corticomeningeal Encephalitis Prior to the Onset of Optic NeuritisTakuya Ataka, Noriyuki Kimura, Etsuro Matsubara
Pageof 12